Delayed and poor engraftment is a well-known complication after T-cell-depleted allogeneic BMT and may favour a transient immune system imbalance with delayed reconstitution of T-cell immunity. 1, 2 Here we describe a 16-year-old patient who developed adenovirus infection followed by severe warm-type autoimmune haemolytic anaemia (wAIHA) after allogeneic unrelated T-cell-depleted BMT. The patient was diagnosed with hypoplastic myelodysplastic syndrome in May 2000 and had initially been treated with steroids. Owing to the lack of a suitable stem cell donor, he was transfused with platelet concentrates and packed red blood cells (RBCs).
In September 2004 he received an HLA-C-mismatch and HLA-DRB1 split-mismatch bone marrow allograft from an unrelated, ABO blood group matched donor. A dose of 1.17 Â 10 6 /kg bodyweight CD34 þ cells was given after conditioning with TBI 2 Â 2 Gy for 3 consecutive days (day À8 until day À6), cyclophosphamide 60 mg/kg i.v. on days À3 and À2 (total dose 7.560 mg) and campath-1H 20 mg for 5 consecutive days once daily i.v. (day À6 until day À2, total dose 100 mg). GVHD prophylaxis consisted of CsA only. Leucocyte engraftment was achieved by day þ 17, but a delayed regeneration of platelets and red cells was observed with persistence of transfusion dependency.
At day þ 119 after allogeneic BMT, a concomitant infection with HHV6 (type B) and adenovirus was diagnosed. Although he developed only mild symptoms of adenovirus infection, he had a remarkable adenovirus type 1 load up to 2.5 Â 10 6 copies/ml plasma. Adenovirus type 3 was isolated from a throat wash specimen of the patient, suggesting acute local adenovirus type 3 and systemic adenovirus type 1 infection.
Although acute adenovirus infection may be a common problem in children, a very poor outcome with high mortality rates has been reported for invasive disease in immunocompromised paediatric patients. Therefore, immunosuppressive therapy was immediately terminated and an antiviral therapy with weekly doses of cidofovir (5 mg/kg) was initiated. This only resulted in temporary reduction of the viral load. Therefore, combined treatment with ribavirin was started. He received cidofovir for 4 weeks (total dose 20 mg/kg) and ribavirin (3 Â 5 mg/kg for 15 days) followed by an oral maintenance therapy with 3 Â 200 mg ribavirin/daily until no adenoviral load could be detected in the plasma and the stool specimens of the patient.
However, mild pancytopenia persisted, requiring further transfusions and, 220 days post transplant, severe wAIHA caused by IgG and IgM autoantibodies developed. In the direct antiglobulin test, RBCs were also found to carry C3d and C3c. Autoantibody in plasma and in eluates prepared from autologous cells reacted with all donor cells tested without evidence of irregular RBC alloantibodies.
Although favourable responses were reported after treatment with rituximab in children with autoimmune haemolytic anaemia (AIHA), 3 this patient failed to respond to rituximab and plasma exchange was initiated. As haemolysis continued after six cycles of plasma exchange, therapy was carried on with immunoadsorption. During the first courses, the titres of free and RBC-bound autoantibodies did not decrease significantly. Haemolysis persisted after five courses of immunoadsorption.
Owing to persisting pancytopenia and a low stem cell content in the initial marrow graft, 2.28 Â 10 6 /kg bodyweight CD34 þ , T-cell-depleted bone marrow stem cells from the same donor were transplanted on day þ 316.
After the second transplantation, haemolysis improved without further treatment, the haemoglobin level, leucocyte and platelet count reached normal values and the boy went back to school with a Lansky index of 100% free of any medication with a current follow-up of 180 days.
To our knowledge, this is the first report on successful treatment of adenovirus infection with antiviral combination therapy including ribavirin/cidofovir and termination of immunosuppression and successful treatment of wAIHA after T-cell-depleted allogeneic BMT with a second boost of T-cell-depleted stem cells.
After allogeneic BMT, unbalanced reconstitution of B-and T-cell lymphopoiesis may favour emergence of oligoclonal proliferation resulting in production of RBC autoantibodies. 4 As the overall response of AIHA to conventional therapy is often unsatisfactory,
